Sign inJoin waitlistJoin the waitlist

JC

Jan Cerny

Adjunct Professor · Univ of Maryland Sch of Med

Credentials: · · · · ·

History

Univ of Maryland Sch of Med
Present

Hematology and Medical Oncology
2023–2026
Internal Medicine
UMass Chan Medical School
2020–2023
Doctor of Medicine
1995–1999

Research

A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
Science Translational Medicine · 2014 · 108 citations
Survival following allogeneic transplant in patients with myelofibrosis
Blood Advances · 2020 · 85 citations
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger…
JAMA Oncology · 2022 · 73 citations

Hillard Lazarus
36 papers
BS
Bipin Savani
31 papers
Wael Saber
31 papers
Siddhartha Ganguly
30 papers
TN
Taiga Nishihori
29 papers
BW
Baldeep Wirk
25 papers
Jean Yared
25 papers
SH
Shahrukh Hashmi
24 papers
Gerhard Hildebrandt
23 papers
Mohamed Dabaja
23 papers
MR
Muthalagu Ramanathan
21 papers
RK
Rammurti Kamble
21 papers

Clinical trials

Evaluating the Safety of Zileuton (Zyflo®) in Combination With Dasatinib (Sprycel®) in Chronic Myelogenous Leukemia
Principal investigator · Terminated · Phase 1
University of Massachusetts, Worcester
2014–2016
Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.
Principal investigator · Terminated · Phase 1
University of Massachusetts, Worcester
2010–2014
Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth
Principal investigator · Withdrawn
University of Massachusetts, Worcester
2009–2100
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029